Percutaneous left ventricular assist device: a systematic review.
10.5124/jkma.2014.57.11.949
- Author:
Youjin JUNG
1
Author Information
1. Division for New Health Technology Assessment, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea. ujin@neca.re.kr
- Publication Type:Original Article
- Keywords:
Heart-assist devices;
Hemodynamics;
Percutaneous coronary intervention;
Shock, cardiogenic
- MeSH:
Cardiac Catheterization;
Cardiac Catheters;
Cohort Studies;
Hand;
Heart-Assist Devices*;
Hemodynamics;
Humans;
Percutaneous Coronary Intervention;
Shock, Cardiogenic
- From:Journal of the Korean Medical Association
2014;57(11):949-956
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The percutaneous left ventricular assist device (pLVAD) was developed for short-term use in patients who require acute circulatory support. The TandemHeart system can be inserted percutaneously in the cardiac catheterization laboratory using standard insertion techniques. The objective of this review is to evaluate the safety and effectiveness of pLVAD only for the TandemHeart. The searches were conducted via electronic databases including Medline, Embase, and the Cochrane library, and 942 non-duplicate citations were retrieved. A total of 20 studies (two randomized controlled trials, one cohort study, and 17 case series) were included for this review. Two review authors independently applied the extracted data and assessed the study quality. On the basis of current data, we recommend that the pLVAD be used as a potential treatment for rescue by the mechanical management of cardiogenic shock. On the other hand, the prophylactic use of the pLVAD requires more evidence from larger more effectively designed studies.
